Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -2222.45% is 50% below its 5-year average of -1482.52%, around the middle of its 5-year range (-6705.79%–-48.48%).
5.77% below its 12-month average of -2101.14%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1495.39%.
OPERATING MARGIN
-2222.45%
OPERATING MARGIN AVG TTM
-2101.14%
OPERATING MARGIN AVG 3Y
-2383.87%
OPERATING MARGIN AVG 5Y
-1482.52%
OPERATING MARGIN AVG 10Y
-1218.35%
OPERATING MARGIN AVG 15Y
-1059.05%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-5.77%
CURRENT VS 3Y AVG
+6.77%
CURRENT VS 5Y AVG
-49.91%
CURRENT VS 10Y AVG
-82.41%
CURRENT VS 15Y AVG
-109.85%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 556 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Fate Therapeutics, Inc.
Market Cap
$279.71M
Operating Margin
-2222.45%
TTM Avg
-2101.14%
3Y Avg
-2383.87%
5Y Avg
-1482.52%
Market Cap
$281.92M
Operating Margin
0.00%
TTM Avg
-13.69%
3Y Avg
-1436.87%
5Y Avg
-1163.68%
Market Cap
$283.11M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$275.02M
Operating Margin
-14.55%
TTM Avg
-6.56%
3Y Avg
-30.72%
5Y Avg
-57.13%
Market Cap
$286.40M
Operating Margin
-1536.91%
TTM Avg
-768.46%
3Y Avg
-1621.10%
5Y Avg
-1715.52%
Market Cap
$287.58M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$265.63M
Operating Margin
-1927.32%
TTM Avg
-1059.56%
3Y Avg
-1070.46%
5Y Avg
-779.81%
Market Cap
$291.39M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$266.17M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fate Therapeutics, Inc. (FATE) | $279.71M | -2222.45% | -2101.14% | -2383.87% | -1482.52% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.92M | 0.00% | -13.69% | -1436.87% | -1163.68% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $283.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aurora Cannabis Inc. (ACB)vs › | $275.02M | -14.55% | -6.56% | -30.72% | -57.13% |
| Abeona Therapeutics Inc. (ABEO)vs › | $286.40M | -1536.91% | -768.46% | -1621.10% | -1715.52% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $287.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| AC Immune S.A. (ACIU)vs › | $265.63M | -1927.32% | -1059.56% | -1070.46% | -779.81% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $291.39M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $266.17M | 0.00% | 0.00% | 0.00% | 0.00% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $264.73M | 0.00% | 0.00% | -5599.55% | -3879.66% |
Gross Margin
-94.1%
Operating Margin
-2222.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -1495.39% |
| 2026-03-31 | -2540.42% |
| 2025-12-31 | -2536.23% |
| 2025-09-30 | -1995.12% |
| 2025-06-30 | -1938.54% |
| 2025-03-31 | -2534.07% |
| 2024-12-31 | -3319.78% |
| 2024-09-30 | -1703.87% |
| 2024-06-30 | -665.73% |
| 2024-03-31 | -2652.88% |
| 2023-12-31 | -2868.44% |
| 2023-09-30 | -2637.81% |
| 2023-06-30 | -6705.79% |
| 2023-03-31 | -48.48% |
| 2022-12-31 | -145.23% |
| 2022-09-30 | -576.67% |
| 2022-06-30 | -448.05% |
| 2022-03-31 | -404.40% |
| 2021-12-31 | -406.48% |
| 2021-09-30 | -383.99% |
| 2021-06-30 | -348.78% |
| 2021-03-31 | -414.74% |
| 2020-12-31 | -210.11% |
| 2020-09-30 | -416.60% |
| 2020-06-30 | -525.29% |
| 2020-03-31 | -1371.45% |
| 2019-12-31 | -1037.76% |
| 2019-09-30 | -1116.47% |
| 2019-06-30 | -854.95% |
| 2019-03-31 | -776.82% |
| 2018-12-31 | -1007.89% |
| 2018-09-30 | -1626.90% |
| 2018-06-30 | -1908.96% |
| 2018-03-31 | -1369.79% |
| 2017-12-31 | -1192.21% |
| 2017-09-30 | -1007.80% |
| 2017-06-30 | -932.75% |
| 2017-03-31 | -970.89% |
| 2016-12-31 | -745.28% |
| 2016-09-30 | -817.64% |
| 2016-06-30 | -779.36% |
| 2016-03-31 | -598.79% |
| 2015-12-31 | -642.38% |
| 2015-09-30 | -616.76% |
| 2015-06-30 | -2193.92% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 504.84% |
| 2013-09-30 | -2463.16% |
| 2013-06-30 | -1472.07% |
| 2013-03-31 | -711.02% |
| 2012-12-31 | -628.93% |
| 2012-09-30 | -691.29% |
